In case C-36/03 The Queen, on the application of Approved Prescription Services Ltd v Licensing Authority; Eli Lilly & Co. Ltd the European Court of Justice ruled earlier today on the circumstances in which an applicant for a certificate of approval of a medical product can rely on the fact that that product is essentially similar to an earlier product where that earlier product is a new pharmaceutical form of an even earlier product, from the point of view of being able to rely on earlier test data in support of the safety of its own product. In this case APS wanted to market a liquid form of fluoxetine which was similar to Eli Lilly's Prozac liquid product, which was a different pharmaceutical form of Eli Lilly's still earlier Prozac capsules.
The IPKat sees this ruling as reducing the red tape that makes it difficult to bring generic and equivalent products to the market. Merpel wonders how much Prozac Eli Lilly and other grug originators will need to take in order to keep cheerful after this ruling.
Prozac: the official story here and here
Prozac: the other side here and here
Prozac and mussels here
PROZAC RULING FACILITATES EUROPEAN DRUG APPROVALS
![PROZAC RULING FACILITATES EUROPEAN DRUG APPROVALS]()
Reviewed by Jeremy
on
Thursday, December 09, 2004
Rating:
Follow the IPKat on LinkedIn 
![[Guest post] EUIPO Second Board of Appeal refers case to Grand Board of Appeal following earlier refusal to register a photograph of a man’s head/face as an EU trade mark](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUj9v-k3DYaSVMR4lsmKDLHVB5nIoINuvZNbH2TQCelrfaAE9qmGSAQs-plzQ7HnZ7Svk_gRdrIODp0Nat5vpWajduit3xkArNhK76AHhX770RIJ62thfCVI5fnvcXU-5zH4NkUSfPY9FjRMFiK7OKJ7m7YSo2FzhyPSoA8ZWCsxaOXb0bBCoPQA/s72-c/Picture%201.png)
![[Guest post] Benelux Office rules on opposition proceedings prepared by ChatGPT](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi29VY0rNNP1Hqyz8RgB47r4q7fhqQfYHxsEbX_RKmT4KU5Y_vg7vB6dsAW91CidjMfJ38klTvD4mMtZb3QmwFPAHaGF88BPttWSbfYvo7UUg7MpFRTNtEjThmG0QaX2qZFFHSnN71i3YQZSBFC0SL7PgkAlme-XH8cSNWRFbOAOuLr_LMOGcImLQ/s72-c/Screenshot%202024-12-04%20at%2020.45.58.png)
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html